Choosing Appropriate Candidates for Left Atrial Appendage Occlusion.
Chengxiang ZhangHao LuYuansong ZhuPublished in: Reviews in cardiovascular medicine (2023)
Atrial fibrillation (AF) is one the most prevalent arrhythmias globally and is associated with a significantly higher risk of morbidity and mortality, including an up to five-fold increase in risk of stroke. While oral anticoagulation therapy remains the standard approach for stroke prevention in nonvalvular AF, left atrial appendage occlusion (LAAO) has emerged as a viable alternative for patients who are intolerant to long-term oral anticoagulation therapy. However, selecting appropriate candidates for LAAO requires a comprehensive evaluation that considers various clinical factors, although this presents a challenge in clinical practice. This review aims to provide an overview of the current recommendations for patient selection in LAAO procedures and the key factors that need to be considered both before and after the procedure, as well as the ongoing advancements in this field that may facilitate the selection of patients for LAAO.
Keyphrases
- atrial fibrillation
- left atrial appendage
- catheter ablation
- oral anticoagulants
- left atrial
- direct oral anticoagulants
- end stage renal disease
- heart failure
- clinical practice
- newly diagnosed
- ejection fraction
- chronic kidney disease
- percutaneous coronary intervention
- prognostic factors
- mesenchymal stem cells
- case report
- bone marrow
- acute coronary syndrome
- patient reported
- coronary artery disease
- minimally invasive
- mitral valve
- brain injury
- cerebral ischemia